Down syndrome study to test memory and thinking changes
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study enrolls adults with Down syndrome to better understand how thinking and memory develop and change over time. It may help by building a “trial-ready” group and by measuring thinking in a careful, consistent way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal helper) can give informed consent, and you can also agree if needed
- You are between 25 and 55 years old
- You have a confirmed diagnosis of Down syndrome from genetic testing or records
- You can do the study for the whole time and complete thinking tests (in English or Spanish)
- Your vision and hearing are good enough for testing, and your thinking age is at least 4 years (and IQ score is 40 or higher)
- You have a reliable study partner (like a caregiver or family member) who knows your health history
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a brain chemical system works in adults with Down syndrome as they age, including how it relates to Alzheimer’s-type brain changes and thinking skills. It uses brain scans and memory/thinking tests to see whether these measures can help track risk or changes over time.
This study tests whether a drug called memantine can help people with Down syndrome. It aims to see if it's safe and if it improves memory or thinking.
This study looks at thinking skills (like memory and problem-solving) in adults with intellectual disabilities, including Down syndrome. You will complete some tests and interviews with a psychologist to understand how these skills work.
This study looks at memory and thinking changes using questionnaires, memory testing, and brain scans. It may help researchers better understand neurodegeneration and dementia and how these problems show up over time.
This trial studies whether a GnRH hormone treatment can improve thinking and memory in people with Down syndrome. It also checks safety and whether the treatment affects brain-related changes seen on MRI.
This trial looks at people over age 50 who have mild thinking or memory problems but do not have dementia by standard clinical criteria. It tests how these early changes are characterized and measured using exams such as blood tests and brain scans, which may help improve understanding and future care.
Hear when a new Down Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.